Published in Stroke on May 01, 2014
Pocket Sized Carotid Stenosis Sceening by Junior Doctors | NCT02992821
Efficacy of Task-specific Training in Physical Activity Level Post-stroke | NCT02937480
Cranial Temperature Early Diagnose Hemorrhagic and Ischemic Stroke (CTedHI) | NCT02601183
Pocket-size Cardiovascular Ultrasound in Stroke | NCT02141932
Microembolisation After Carotid Revascularisation | NCT03303430
Cardiovascular Effects of Acute Exercise Post-Stroke (ACES) | NCT03570216
Telestroke for Comprehensive Stroke Care in Acute Stroke Ready Hospitals (TELECAST) | NCT03672890
TREAT Foot Drop After Stroke With Ankle Robot (TREAT) | NCT04137809
Apnea, Stroke and Incident Cardiovascular Events (ASCENT) | NCT04399200
Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds (AIM) | NCT04504864
Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic (TELECAST-CSC) | NCT04761874
Effectiveness of NIRS (Near-Infrared Spectroscopy) at Acute Ischemic Stroke Patients | NCT04904172
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. N Engl J Med (2016) 4.52
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Neural function, injury, and stroke subtype predict treatment gains after stroke. Ann Neurol (2014) 1.82
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet (2016) 1.56
Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials. J Am Coll Cardiol (2016) 1.55
Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses. BMJ (2016) 1.41
Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis. JAMA (2017) 1.40
Comparison of hemostatic dressings for superficial wounds using a new spectrophotometric coagulation assay. J Transl Med (2015) 1.38
CHADS2 and CHA2DS2-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation. J Atheroscler Thromb (2016) 0.98
Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke. Transl Stroke Res (2015) 0.96
Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack. CMAJ (2017) 0.95
Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation. Front Physiol (2014) 0.90
Controversies in cardioembolic stroke. Curr Treat Options Cardiovasc Med (2015) 0.90
The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a single-center experience. Neurol Sci (2015) 0.88
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs (2016) 0.88
Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries. J Stroke (2015) 0.88
Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis. Stroke (2016) 0.87
Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol (2015) 0.87
Optimal combination secondary prevention drug treatment and stroke outcomes. Neurology (2014) 0.86
2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation). Korean Circ J (2016) 0.84
Biomarker panels in ischemic stroke. Stroke (2015) 0.84
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack. Am J Med (2015) 0.84
Use of low-dose aspirin as secondary prevention of atherosclerotic cardiovascular disease in US adults (from the National Health Interview Survey, 2012). Am J Cardiol (2015) 0.84
How I treat and manage strokes in sickle cell disease. Blood (2015) 0.83
Patent Foramen Ovale and Stroke-Current Status. J Stroke (2015) 0.83
Clinical Risk Factors Affecting Procedure-Related Major Neurological Complications in Unruptured Intracranial Aneurysms. Yonsei Med J (2015) 0.83
Anatomical Considerations on Surgical Anatomy of the Carotid Bifurcation. Anat Res Int (2016) 0.82
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study. EBioMedicine (2015) 0.82
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association. Circulation (2017) 0.82
Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients. Clin Res Cardiol (2015) 0.82
The urgent need for contemporary clinical trials in patients with asymptomatic carotid stenosis. Neurology (2016) 0.82
Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study. Sleep Breath (2015) 0.81
Harnessing smartphone technologies for stroke care, rehabilitation and beyond. BMJ Innov (2015) 0.81
Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet (2017) 0.81
Lowering of blood pressure for recurrent stroke prevention. Stroke (2014) 0.81
Multimodal secondary prevention behavioral interventions for TIA and stroke: a systematic review and meta-analysis. PLoS One (2015) 0.81
Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis. J Am Heart Assoc (2015) 0.81
How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices. J Stroke (2016) 0.81
Optimal combination treatment and vascular outcomes in recent ischemic stroke patients by premorbid risk level. J Neurol Sci (2015) 0.81
Left Atrial Appendage Function and Stroke Risk. Stroke (2015) 0.80
A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers. J Interv Card Electrophysiol (2015) 0.80
China Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A new, prospective, multicenter, randomized controlled trial in China. Interv Neuroradiol (2015) 0.80
Adherence to oral anticoagulant therapy in secondary stroke prevention - impact of the novel oral anticoagulants. Patient Prefer Adherence (2015) 0.80
Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke: Traditional and Bayesian Network Meta-analysis of Randomized Trials. Medicine (Baltimore) (2016) 0.79
Imaging Parameters and Recurrent Cerebrovascular Events in Patients With Minor Stroke or Transient Ischemic Attack. JAMA Neurol (2016) 0.79
Infarct location and sleep apnea: evaluating the potential association in acute ischemic stroke. Sleep Med (2015) 0.79
Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA. Front Neurol (2015) 0.79
Obstructive sleep apnea is independently associated with arterial stiffness in ischemic stroke patients. J Neurol (2015) 0.79
Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag (2015) 0.79
Stroke Risk Factors, Genetics, and Prevention. Circ Res (2017) 0.78
The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR. Anatol J Cardiol (2015) 0.78
Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited. J Clin Med Res (2016) 0.78
Risk Factors for Silent Lacunar Infarction in Patients with Transient Ischemic Attack. Med Sci Monit (2016) 0.78
Personalized medicine and stroke prevention: where are we? Vasc Health Risk Manag (2015) 0.78
Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. Ann Neurol (2016) 0.78
Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study. Cardiovasc Diabetol (2015) 0.78
Forced Aerobic Exercise Enhances Motor Recovery After Stroke: A Case Report. Am J Occup Ther (2015) 0.78
A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale. BMC Public Health (2014) 0.78
Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice. Front Neurol (2016) 0.78
Role of sleep-disordered breathing and sleep-wake disturbances for stroke and stroke recovery. Neurology (2016) 0.78
Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants. Arrhythm Electrophysiol Rev (2014) 0.78
Cognitive impairment and stroke in elderly patients. Vasc Health Risk Manag (2016) 0.78
Association between hospitalization and care after transient ischemic attack or minor stroke. Neurology (2016) 0.78
Recurrent mild cerebral ischemia: enhanced brain injury following acute compared to subacute recurrence in the rat. BMC Neurosci (2016) 0.78
Lipids and Cerebrovascular Disease: Research and Practice. Stroke (2015) 0.78
Clinical relevance of clopidogrel-proton pump inhibitors interaction. World J Gastrointest Pharmacol Ther (2015) 0.78
Pathophysiology and management of reperfusion injury and hyperperfusion syndrome after carotid endarterectomy and carotid artery stenting. Exp Transl Stroke Med (2016) 0.78
Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis. J Neurol Sci (2017) 0.78
Health care utilization in older people with cardiovascular disease in China. Int J Equity Health (2015) 0.78
Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. J Atheroscler Thromb (2016) 0.77
Identification of Barriers to Stroke Awareness and Risk Factor Management Unique to Hispanics. Int J Environ Res Public Health (2015) 0.77
Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure. Stroke (2014) 0.77
Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study. PLoS One (2016) 0.77
Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages. Semin Nephrol (2015) 0.77
Can Continuous Positive Airway Pressure Reduce the Risk of Stroke in Obstructive Sleep Apnea Patients? A Systematic Review and Meta-Analysis. PLoS One (2016) 0.77
Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism. BMJ Glob Health (2016) 0.77
TIA Management: Should TIA Patients be Admitted? Should TIA Patients Get Combination Antiplatelet Therapy? Neurohospitalist (2015) 0.77
An effective support system of emergency medical services with tablet computers. JMIR Mhealth Uhealth (2015) 0.77
CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study. J Am Heart Assoc (2015) 0.77
Transcatheter closure of PFO as secondary prevention of cryptogenic stroke. Herz (2016) 0.77
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation. J Stroke (2016) 0.77
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation. Ann Hematol (2015) 0.77
Field Synopsis of the Role of Sex in Stroke Prediction Models. J Am Heart Assoc (2016) 0.77
Large artery: an important target for cerebral small vessel diseases. Ann Transl Med (2014) 0.77
Migraine as a risk factor for young patients with ischemic stroke: a case-control study. Neurol Sci (2017) 0.76
Blood pressure control to prevent decline in cognition after stroke. Vasc Health Risk Manag (2015) 0.76
Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci (2016) 0.76
Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Int J Stroke (2015) 0.76
The quality of reporting of randomized controlled trials of electroacupuncture for stroke. BMC Complement Altern Med (2016) 0.76
A possible new focus for stroke treatment - migrating stem cells. Expert Opin Biol Ther (2015) 0.76
Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease. Curr Alzheimer Res (2016) 0.76
Migraine with aura and patent foramen ovale: myth or reality? Neurol Sci (2015) 0.76
Implementation of a new guideline in cardiovascular secondary preventive care: subanalysis of a randomized controlled trial. BMC Cardiovasc Disord (2016) 0.76
Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions. Brain Behav (2016) 0.76
Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol (2016) 0.76
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med (2005) 13.14
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Stroke. Lancet (2008) 9.51
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med (2010) 6.21
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03
Factors associated with medical students' career choices regarding internal medicine. JAMA (2008) 5.54
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
Amiodarone versus sotalol for atrial fibrillation. N Engl J Med (2005) 5.01
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med (2009) 4.71
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA (2003) 4.38
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J (2005) 4.37
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation (2003) 4.19
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol (2008) 3.98
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71
Histopathological assessment of fatal ipsilateral intraparenchymal hemorrhages after the treatment of supraclinoid aneurysms with the Pipeline Embolization Device. J Neurosurg (2013) 3.65
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA (2003) 3.49
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation (2006) 3.40
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Newly identified events in the RE-LY trial. N Engl J Med (2010) 3.35
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Association of Clinical Researchers and Educators a statement on relationships between physicians and industry. Endocr Pract (2012) 3.27
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol (2010) 3.26
Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology (2012) 3.20
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
An evidence-based causative classification system for acute ischemic stroke. Ann Neurol (2005) 3.09
Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med (2009) 3.07
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med (2010) 3.05
Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J (2006) 3.05
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87